Freshers QC Jobs
--Must See--

Freshers QC Jobs at Hetero Biopharma Ltd – Applications Invited

Freshers Jobs at Hetero Biopharma Ltd. Freshers QC Jobs at Hetero Biopharma Ltd – Applications Invited. Hetero Biopharma Ltd Quality Control Vacancy. Hetero Biopharma Ltd Microbiology Job Openings for MSc/BTech/MTech Biotech/ Biochem/ Microbiology Jr Officer vacancy. Interested and eligible applicants can check out all of the details on the same below:

Name of the Post(s): QC & Microbiology

Experience: 0 year(s) of Experience

Location: Hyderabad

Salary: Not Disclosed by Recruiter

Industry: Pharma / Biotech / Clinical Research

Functional Area: Other

Employment Type: Full Time, Permanent

Company Name: Hetero Biopharma Ltd

Department: QC/Microbiology

Designation: Jr Officer

Experience: Freshers

Education Qualification:

M.Sc(Biochemistry/Biotechnology/Microbiology)/B.Tech(Biotechnology)/M.Tech(Biotechnology)

Education:

  • UG: B.Tech/B.E. – Bio-Chemistry/Bio-Technology
  • PG: MS/M.Sc(Science) – Bio-Chemistry, Biotechnology, Microbiology

How to Apply:

Interested candidates share profile to [email protected],
[email protected].

Editor’s Note: Freshers QC Jobs at Hetero Biopharma Ltd – Applications Invited. Please make sure that you are subscribed to the Biotecnika Times Newsletter and our YouTube channel to be notified of all of the latest in the industry. Follow us on all of our social media like Twitter, Telegram, Facebook and Instagram.

BioTecNika Bureau
BioTecNika Bureau is the official editorial and research desk of BioTecNika, dedicated to bringing reliable updates, career guidance, exam information, job alerts, scholarships, industry trends, and learning resources for life science and biotechnology students, researchers, and professionals. Since 2006, BioTecNika has been committed to simplifying complex scientific information and helping learners make informed academic and career decisions.

1 COMMENT

  1. I want to apply i have send my resume to the given mail id pliz tell me if i got any chance.

Comments are closed.